Final Results

AI SummaryClose X

Cambridge Nutritional Sciences PLC (CNSL) announced its audited final results for the year ended 31 March 2025, showing significant progress after restructuring. Total income increased by 12.7% to £11.1 million (2024: £9.9 million), while revenue decreased by 14.8% to £8.3 million (2024: £9.8 million). The gross margin improved to 65.3% (2024: 61.9%), and adjusted EBITDA* grew by 115.4% to £0.4 million (2024: £0.2 million). Profit before taxation increased by 310% to £1.6 million (2024: a loss of £0.7 million). Cash and deposits decreased by 10.6% to £4.9 million (2024: £5.4 million). Operational highlights include CNSLab productivity improvements, a 41% reduction in scrap yields, investment in automation, a 9% increase in UK lab sales, and the UK deployment of the MyHealthTracker app. The company also noted a successful resolution of all outstanding legal cases.

Disclaimer*

UK 100

Latest directors dealings